Biocartis Group NV buy melinda
Start price
04.07.17
/
50%
€10.01
Target price
04.10.17
€10.70
Performance (%)
6.89%
End price
04.10.17
€10.70
Summary
This prediction ended on 04.10.17 with a price of €10.70. The BUY prediction by melinda finished with a performance of 6.89%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocartis Group NV | - | - | - | - |
| iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
| iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
| iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
| iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by melinda for this prediction
In the thread Biocartis Group NV diskutieren
Biocartis Gruppe ist spezialisiert auf die Entwicklung von molekularen Diagnosesysteme. Die Produkte, insbesondere in den Bereichen Onkologie und Infektionskrankheiten, die Analyse von Biomolekülen im Zusammenhang mit Risikofaktoren, Früherkennung
Stopped prediction by melinda for Biocartis Group NV
Biocartis Group NV
Start price
Target price
Perf. (%)
€10.01
04.07.17
04.07.17
€10.70
04.10.17
04.10.17
6.89%
04.10.17
04.10.17
